List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 69 studies with search of:   "Ipsen" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: EGb 761® (Tanakan®)
2 Not yet recruiting Non Interventional Post Marketing Programme in Acromegaly
Condition: Acromegaly
Intervention:
3 Completed Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Botulinum toxin type A (Dysport®)
4 Not yet recruiting Epidemiology Study on Insulin-Like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)
Condition: Idiopathic Short Stature
Intervention:
5 Active, not recruiting Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
Condition: Acromegaly
Interventions: Drug: lanreotide (Autogel formulation);   Drug: Pegvisomant
6 Completed Open-Label Extension Study of Botulinum Type A Toxin (Dysport®) for the Treatment of Cervical Dystonia
Condition: Cervical Dystonia
Intervention: Drug: Botulinum type A toxin (Dysport) - duration: maximum of 4 cycles/injections
7 Completed Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
Condition: Myofascial Pain Syndromes
Intervention: Drug: Botulinum type A toxin (Dysport®)
8 Active, not recruiting A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
Conditions: Memory Disorders, Age-Related;   Retention Disorders, Cognitive
Interventions: Drug: EGb 761® (Tanakan®);   Other: Placebo
9 Completed Effects on Quality of Life Following Dysport Treatment in Post-Stroke Spasticity of the Arm
Conditions: Cerebrovascular Accident;   Muscle Spasticity
Intervention: Drug: Botulinum type A toxin (Dysport)
10 Recruiting Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
Condition: Freidreich Ataxia
Interventions: Drug: EGb 761 120 mg bid;   Drug: Placebo 1 tablet BID
11 Completed Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
Condition: Digestive Fistulae
Interventions: Drug: Lanreotide microparticles;   Drug: Placebo
12 Active, not recruiting Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)
Condition: Small Cell Lung Cancer
Intervention: Drug: Diflomotecan (BN80915)
13 Completed Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
Condition: Hemifacial Spasm
Intervention: Drug: Botulinum type A toxin (Dysport®) - one single injection
14 Completed Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children
Condition: Diarrhoea
Intervention: Drug: Smecta (Diosmectite), duration of treatment - 7 days
15 Completed A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
Condition: Acromegaly
Intervention:
16 Terminated Lanreotide (Somatuline Autogel) in Thyroid-Associated Ophthalmopathy Treatment
Condition: Thyroid-Associated Ophthalmopathy
Intervention: Drug: Lanreotide (Autogel formulation). Duration of treatment - 3 injections, 1 every 28 days
17 Recruiting Predictive Factors of Response to Somatostatin Analogues in Acromegalic Patients With Persistent Disease Following Surgery
Condition: Acromegaly
Intervention:
18 Completed Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in Adults
Condition: Diarrhea
Intervention: Drug: Diosmectite (Smecta®)
19 Recruiting A Post Marketing Surveillance Program for NutropinAq® in Pediatric Growth Disorders
Condition: Growth Hormone Disorders
Intervention:
20 Completed Post Marketing Surveillance Study of Dysport
Conditions: Blepharospasm;   Hemifacial Spasm;   Cervical Dystonia;   Spasmodic Torticollis;   Cerebral Palsy;   Muscle Spasticity;   Cerebrovascular Accident;   Equinus Deformity;   Facial Hyperdynamic Lines
Intervention:

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services